Trial Profile
Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2014
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Estradiol
- Indications Vasomotor symptoms
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 29 Mar 2014 New trial record